As reported, the balloon of a 5f mynx control vascular closure device (vcd) burst during the ballooning process.There was no reported patient injury.The device was used in a transcatheter arterial chemoembolization (tace) treatment.Other procedural details were requested but are unknown, unavailable, not answered, or not applicable.The device will be returned for evaluation.
|
As reported, the balloon of a 5f mynx control vascular closure device (vcd) burst during the ballooning process.There was no reported patient injury.The device was used in a transcatheter arterial chemoembolization (tace) treatment.Other procedural details were requested but are unknown, unavailable, not answered, or not applicable.A non-sterile ¿mynx control vcd 5f¿ involved in the reported complaint was returned for investigation.Visual inspection of the received device showed that button 1 and button 2 were not depressed.The syringe and procedural sheath were not received for evaluation.The stopcock was observed opened, and the balloon was found fully deflated.In addition, the sealant was found in its manufactured position, fully covered by the sealant sleeves, and the sealant was not exposed to blood.In addition, no damages were observed to the sealant sleeves assembly.Per functional analysis, an inflation/deflation test was performed per the mynx control instructions for use (ifu).The results revealed a leak in the balloon of the returned device.Per microscopic analysis, visual inspection at high magnification revealed a longitudinal tear in the balloon of the returned device.The reported event of ¿balloon-balloon loss of pressure¿ was confirmed through analysis of the returned device.However, the exact cause of the longitudinal tear found could not be conclusively determined during analysis.Based on the limited information available for review and product analysis, it is difficult to determine what factors may have contributed to the loss of pressure reported.However, access site vessel characteristics (although not reported) and/or concomitant device factors (although not returned) most likely contributed to the reported event since a calcified vessel, and/or concomitant device factors (such as a damaged procedural sheath, stent, or vascular graft) can cause this type of damage to the balloon.According to the instructions for use (ifu), which is not intended as a mitigation, ¿the safety and effectiveness of the mynx control vcd have not been established in the following patient populations: patients with clinically significant peripheral vascular disease in the vicinity of the puncture.¿ also stated in the ifu during product preparation, ¿confirm via femoral arteriogram: common femoral artery single wall puncture.Evidence of adequate flow.No evidence of significant pvd in the vicinity of the puncture.¿ additionally, the device preparation states to discard the device if the balloon does not maintain pressure.Neither the product analysis, nor the information available for review suggest that the reported failure could be related to the design or manufacturing process of the unit.Therefore, no corrective/preventative actions will be taken at this time.
|